Notes
Slide Show
Outline
1
Fungicide Resistance:
Past, Present and Future Outlook
  • Frank P. Wong
  • Department of Plant Pathology
  • University of California, Riverside
2
 
3
 
4
 
5
Fungicides and IPM
  • Fungal diseases are the number one cause of plant loss caused by microorganisms
  • Fungicides are a valuable part of IPM programs
    • Tolerance for disease is low
    • No effective cultural controls
    • Most energy efficient way to control fungi
  • Use fungicides properly and maintain their long-term utility
6
Fungicide Resistance
  • Occurs when fungi adapt to fungicides which leads to
    • immunity
    • reduced efficacy
  • Inheritable trait, passed on from one generation to the next
  • Impact
    • Direct crop loss
    • Wasted time and money
    • Loss of disease control options
7
Resistance in Turf and Production Nurseries
  • Both are high risk situations
  • Monoculture
  • Constant cropping/perennial crop system
  • High value/low disease tolerance
  • Often limited in cultural control options/choices for resistant varieties


8
History of Fungicide Resistance
  • Not of major concern until the introduction of site-specific fungicides (1970s)
    • Multi-site (captan, chlorothalanil, EBDCs, sulfur)
    • Single-site (benzimidazoles, DMIs, QoIs)
  • Site-specific fungicide benefits:
    • Systemic/ curative properties
    • Reduced non-target effects/environmental impact
  • Resistance development to these is much easier
    • Small genetic changes in fungi overcome fungicides targeted at one enzyme or biochemical pathway

9
History of Fungicide Resistance
10
Fungicide Resistance
  • Nursery
    • Botrytis grey mold
      • dicarboximides, benzimidazoles
    • Phytophthora root rots
      • phenylamides
  • Turf
    • Anthracnose
      • benzimidazoles, QoIs, sterol biosynthesis inhib.
    • Dollar spot
      • dicarboximides, benzimidazoles
    • Grey leaf spot
      • benzimidazoles, QoIs
    • Pythium blight
      • phenylamides


11
How Does Resistance Occur?
  • Resistant individuals occur naturally at a very low frequency (< 0.0001%?)
    • Natural mutants
    • Sexual and asexual recombination
  • Resistant individuals are selected by fungicide applications
  • Repeated fungicide use increases the frequency of resistant individuals
  • When this frequency is high enough, control is impacted – “practical resistance”
  • Fungicides do not “change” the fungus - only the population structure


12
Selection for Resistance
13
Resistance Risk
  • Many factors contribute to the risk of resistance for any given fungcide


14
Biochemical Mode of Action
  • BMOA is the primary determinant of the fungicidal activity of a chemical
  • Most fungicides function by binding to fungal cell components and disrupting key metabolic functions
  • Target specificity
    • Multi-site Inhibitors
    • Single-site Inhibitors

15
Multi-site Inhibitors
  • Affect multiple metabolic processes
16
Multi-site Inhibitors
17
Multi-site Inhibitors
18
Single-site Inhibitors
  • Affect a specific metabolic process
  • Bind to proteins via “lock and key” process
19
Single-site Inhibitors
  • Amino Acid and Protein Synthesis
    • Anilinopyrimidines
  • Sterol Biosynthesis
    • DMIs
  • Respiration
  • (MET complex III)
    • QoIs
  • Respiration (unknown)
    • Phenylpyrroles
  • Lipid Biosynthesis
    • Sub. Aromatic Hydrocarbons
    • Dicarboxymides
  • mRNA Synthesis
    • Phenylamides
  • Nuclear Division
    • Benzimidazoles
  • Respiration (MET complex II)
    • Carboxins



20
Cross-Resistance
  • Cross-resistance affects all fungicides with a similar biochemical mode of action
  • Once resistance develops to a fungicide - all members of the same cross resistance group are affected
  • Examples:
    • Benzimidazole resistance affects benlate, topsin-M
    • QoI resistance affects Quadris, Abound, Flint, Headline, Cabrio
    • DMI resistance affects Rally, Elite, Rubigan, Orbit
21
Pathogen Biology
  • Resistance occurs more frequently in pathogens that:
    • Have a short generation time
    • Have a high frequency of reproduction
    • Are prone to genetic changes
  • Each application is a selection event
  • Higher chance of selection for resistance against large, fast reproducing pathogens
22
Relative Resistance Risk
23
Use Patterns
  • Every application is a selection event
  • Curative and eradicant applications are worse:
    • Incomplete control
    • Selection against a larger population
  • Reduced rate applications are worse:
    • Incomplete control
    • Selection against a larger population
24
Physical Mode of Action
25
PLASVI Seedling Bioassay:
Protectant and Postinfection Activity
26
Activity of Azoxystrobin Against Grapevine Powdery Mildew
27
Patterns of Resistance Development
  • Resistance develops differently dependent on how many genes are involved in resistance
    • Polygenic (many genes)
      • Quantitative or “shifting” resistance
      • DMIs, SIs, dicarboximides
    • Monogenic (one gene)
      • Qualitative or “disruptive” resistance
      • Benzimidazoles, phenylamides, QoIs
28
 
29
Patterns of Resistance Development
  • Shifting
    • Reduced control, especially at low label rates
    • Reduced application intervals
    • Slower to develop over time
  • Disruptive
    • No control at field rates
    • Failures can be sudden and dramatic
30
Distribution of NY Grapevine Powdery Mildew Sensitivities to Myclobutanil
1995 vs. 1999
31
Grapevine Powdery Mildew Control
32
 
33
Anthracnose Control
34
Resistance Management Strategies
  • Reduce the overall number of selection events
  • Alternate fungicides with different modes of action
    • Partner must also work!
  • Mixtures?
    • site-specific + multi site = 1 selection event
    • site-specific + site specific = 1 selection event each (selection for double resistance)
    • Worse when mixture partner is used at ½ rate
    • Partner must provide 80% control to prevent resistance selection (Delp 1986)

35
Selection for Resistance
36
Fungicide Alternation
37
Who Mandates Resistance Management Enforcement?
  • FRAC – intra-industry committee that determines use limits for new and current chemistries
  • Membership is primarily from large producers and focuses on larger fungicide groups
  • Primarily based in EU
  • Enforces resistance management through label restrictions
38
Fungicide Resistance Management - An Industry Effort
39
Future Outlook for Fungicide Resistance: Impact of FQPA and EPA standards
  • Older multi-site chemistries will have increased restrictions
    • B2 carcinogens
    • new efforts to examine SIs
  • All new fungicides must have reduced non-target effects
  • All new fungicides will be single-site
  • New fungicides will take longer to develop and register


40
Summary
  • Resistance is the Achilles’ heel of all site-specific fungicides
  • Resistance occurs naturally
  • Avoid the development of practical resistance
  • Many mechanisms of resistance
    • Know the chemical class of fungicides you use
    • Know the cross-resistance classes
  • Two resistance patterns:
    • Disruptive resistance = “all or nothing”
    • Shifting resistance = “partial loss”

41
Summary
  • Reduce the total number of fungicide applications and resistance selection events
    • Alternate between cross-resistance groups
    • Know the biochemical mode of action and cross resistance groups
  • Reduce the population size being selected against
    • Practice good disease management
    • Don’t wait until the epidemic is raging
  • Use fungicides effectively and efficiently
    • Time applications based upon knowledge of disease epidemiology and development
    • Don’t cheat with rates or application intervals
    • Don’t rely on curative/eradicant activity
    • It may cost you more in the end

42